UK markets open in 3 hours 3 minutes
  • NIKKEI 225

    27,774.93
    -2.97 (-0.01%)
     
  • HANG SENG

    19,320.62
    +645.27 (+3.46%)
     
  • CRUDE OIL

    80.61
    +0.63 (+0.79%)
     
  • GOLD FUTURES

    1,822.30
    +12.70 (+0.70%)
     
  • DOW

    34,429.88
    +34.88 (+0.10%)
     
  • BTC-GBP

    14,003.42
    +156.94 (+1.13%)
     
  • CMC Crypto 200

    409.63
    +8.21 (+2.04%)
     
  • ^IXIC

    11,461.50
    -20.90 (-0.18%)
     
  • ^FTAS

    4,138.81
    -2.23 (-0.05%)
     

Brokers bullish on WuXi Biologics (Cayman) shares

The WuXi Biologics (Cayman) (HKG:2269) share price has risen by 41.2% over the past month and it’s currently trading at HK$76.7. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, WuXi Biologics (Cayman) currently has:

  • 12 Buy recommendations

  • 1 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO HKG:2269 »

Researching beyond analyst forecasts

At its current price of HK$76.7, shares in WuXi Biologics (Cayman) are trading at a discount of -48.2% to its 52 week high price. The 1-year performance of the shares has been -46.1%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of WuXi Biologics (Cayman) it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with WuXi Biologics (Cayman) that you can find out about here.